Todd Foley
CIK: 0001473930
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aktis Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 12, 2026AKTS
Aktis Oncology, Inc.
Conversion(C)Indirect597.4K shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
Conversion(C)Indirect2.7M shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
Conversion(C)Indirect716.9K shares- - Jan 12, 2026AKTS
Aktis Oncology, Inc.
Purchase(P)Indirect232.9K shares at avg. $18.00$4.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion(C) | 597,391 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion(C) | 2,688,270 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Conversion(C) | 716,872 | - | $0 | Indirect |
| Jan 12, 2026 | AKTS Aktis Oncology, Inc. | Purchase(P) | 232,870 | $18.00 | $4,191,660 | Indirect |
1-4 of 4 transactions
About Foley Todd
Foley Todd (SEC CIK 0001473930) files insider reports with the SEC as Director of Aktis Oncology, Inc. (AKTS).
Signal8 holds 2 ownership filings by Foley Todd (1 Form 3, 1 Form 4), filed between Jan 8, 2026 and Jan 14, 2026. Those filings report 4 transactions, the latest on Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Foley Todd's filings is in BOSTON, MA.
Recent filings by Foley Todd
Other insiders filing for Aktis Oncology, Inc. (AKTS)
- Czibere Akos, Chief Medical Officer
- Herrmann Ken, Director
- Ron-Bigger Shulamit, Chief Operating Officer
- Gormley Glenn, Director
- ELI LILLY & Co, 10% Owner
- MPM BIOVENTURES 2018, L.P., 10% Owner